Antibody fragment { Fab('ab')₂ }

[{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa1c/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa1c/5a8450b1b8bc53001418401d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa1b/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa1b/5a8450b1b8bc53001418401d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa1a/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa1a/5a8450b1b8bc53001418401d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa19/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa19/5a8450b1b8bc53001418401d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa18/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa18/5a8450b1b8bc53001418401d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa17/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa17/5a8450b1b8bc53001418401d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa16/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa16/5a8450b1b8bc53001418401d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa15/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa15/5a8450b1b8bc53001418401d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa14/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa14/5a8450b1b8bc53001418401d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa13/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa13/5a8450b1b8bc53001418401d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa12/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa12/5a8450b1b8bc53001418401d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa11/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa11/5a8450b1b8bc53001418401d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa10/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa10/5a8450b1b8bc53001418401d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b46139d470ae0001425fa0f/5a8450b1b8bc53001418401d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b46139d470ae0001425fa0f/5a8450b1b8bc53001418401d.png"}]